Residential College | false |
Status | 已發表Published |
Low-Dose 68 Ga-PSMA Prostate PET/MRI Imaging Using Deep Learning Based on MRI Priors | |
Deng, Fuquan1,2,3; Li, Xiaoyuan4; Yang, Fengjiao4; Sun, Hongwei5; Yuan, Jianmin6; He, Qiang6; Xu, Weifeng2; Yang, Yongfeng1,3; Liang, Dong1,3; Liu, Xin1,3; Mok, Greta S.P.7; Zheng, Hairong1,3; Hu, Zhanli1,3 | |
2022-01-26 | |
Source Publication | Frontiers in Oncology |
ISSN | 2234-943X |
Volume | 11Pages:818329 |
Abstract | Background: 68 Ga-prostate-specific membrane antigen (PSMA) PET/MRI has become an effective imaging method for prostate cancer. The purpose of this study was to use deep learning methods to perform low-dose image restoration on PSMA PET/MRI and to evaluate the effect of synthesis on the images and the medical diagnosis of patients at risk of prostate cancer. Methods: We reviewed the 68 Ga-PSMA PET/MRI data of 41 patients. The low-dose PET (LDPET) images of these patients were restored to full-dose PET (FDPET) images through a deep learning method based on MRI priors. The synthesized images were evaluated according to quantitative scores from nuclear medicine doctors and multiple imaging indicators, such as peak-signal noise ratio (PSNR), structural similarity (SSIM), normalization mean square error (NMSE), and relative contrast-to-noise ratio (RCNR). Results: The clinical quantitative scores of the FDPET images synthesized from 25%- and 50%-dose images based on MRI priors were 3.84±0.36 and 4.03±0.17, respectively, which were higher than the scores of the target images. Correspondingly, the PSNR, SSIM, NMSE, and RCNR values of the FDPET images synthesized from 50%-dose PET images based on MRI priors were 39.88±3.83, 0.896±0.092, 0.012±0.007, and 0.996±0.080, respectively. Conclusion: According to a combination of quantitative scores from nuclear medicine doctors and evaluations with multiple image indicators, the synthesis of FDPET images based on MRI priors using and 50%-dose PET images did not affect the clinical diagnosis of prostate cancer. Prostate cancer patients can undergo 68 Ga-PSMA prostate PET/MRI scans with radiation doses reduced by up to 50% through the use of deep learning methods to synthesize FDPET images. |
Keyword | Deep Learning Discrete Wavelet Transform Low-dose Restoration Pet/mri Prostate |
DOI | 10.3389/fonc.2021.818329 |
URL | View the original |
Indexed By | SCIE |
Language | 英語English |
WOS Research Area | Oncology |
WOS Subject | Oncology |
WOS ID | WOS:000752718100001 |
Scopus ID | 2-s2.0-85124510984 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | DEPARTMENT OF ELECTRICAL AND COMPUTER ENGINEERING |
Corresponding Author | Hu, Zhanli |
Affiliation | 1.Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China 2.Computer Department, North China Electric Power University, Baoding, China 3.Chinese Academy of Sciences Key Laboratory of Health Informatics, Shenzhen, China 4.Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China 5.United Imaging Research Institute of Intelligent Imaging, Beijing, China 6.Central Research Institute, United Imaging Healthcare Group, Shanghai, China 7.Biomedical Imaging Laboratory (BIG), Department of Electrical and Computer Engineering, Faculty of Science and Technology, University of Macau, Avenida da Universidade, Macao |
Recommended Citation GB/T 7714 | Deng, Fuquan,Li, Xiaoyuan,Yang, Fengjiao,et al. Low-Dose 68 Ga-PSMA Prostate PET/MRI Imaging Using Deep Learning Based on MRI Priors[J]. Frontiers in Oncology, 2022, 11, 818329. |
APA | Deng, Fuquan., Li, Xiaoyuan., Yang, Fengjiao., Sun, Hongwei., Yuan, Jianmin., He, Qiang., Xu, Weifeng., Yang, Yongfeng., Liang, Dong., Liu, Xin., Mok, Greta S.P.., Zheng, Hairong., & Hu, Zhanli (2022). Low-Dose 68 Ga-PSMA Prostate PET/MRI Imaging Using Deep Learning Based on MRI Priors. Frontiers in Oncology, 11, 818329. |
MLA | Deng, Fuquan,et al."Low-Dose 68 Ga-PSMA Prostate PET/MRI Imaging Using Deep Learning Based on MRI Priors".Frontiers in Oncology 11(2022):818329. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment